International Journal of Cancer Immunology & Immunotherapy (IJCII) is a broad-based peer review open access journal, which focus to publish quality scientific researches with respect to the scope of the journal. We aim to disseminate quality & genuine scientific contents to create reputed archival of literature in the field of Science, Technology & Medicine.

We encourage authors, who always have shown more interest to publish his work in the prestigious journals, and avail them the freely to the scientific community. Publication is a long path from author to reader, so our aim to remove the barrier between author and reader or the end user for the free flow of scientific information by making the journals Open Access. This provide a rapid turn-around time possible for reviewing and publishing and to disseminate the articles freely for research, teaching and reference purposes.

All works published by Graphy Publications are under the terms of the Creative Commons Attribution License. The license grants copyrights to the author concerned and make the articles available for their dissemination. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. IJCII supports the Bethesda Statement on Open Access Publishing.

International Journal of Cancer Immunology & Immunotherapy is Open Access journal, covers wide area for publication in the field of cancer immunology. IJCII publishes most exciting original research articles, and review articles, related to all aspects of cancer immunology & immunotherapy.

  • Chemotherapy & Radiotherapy
  • Tumor Antigens
  • Serological Immune Biomarkers
  • Prognostic Biomarker Studies
  • High Content Immunohistological Studies
  • Tumor Immunology and Immunotherapy
  • Tumor-promoting Inflammation
  • Immunomodulatory Effects of Cancer Treatment
  • Immune Regulation & Response
  • Innate & Adaptive Anti-tumor Immune
  • Radiation and Immune Therapy
  • Gene Expression Studies
  • Cancer Immunology and Chemotherapy
  • Endogenous Antitumor Immunity
  • Immune Regulation & Suppression
  • Cellular Therapy